Moreover, our results provided new mechanistic insights into the crucial roles of AIM2 in suppressing Gli1 through regulating AKT/mTOR pathway, which reveals a possible implication for new approaches to CRC therapy. This evidence concerns the gene AIM2 and colorectal carcinoma.